Protection against oxaliplatin acute neurosensory toxicity by venlafaxine.

Anticancer Drugs

Unité d'Oncologie Médicale, Service de Médecine Interne 1, Groupe Hospitalier Cochin, Paris, France.

Published: July 2003

Venlafaxine (Effexor; Wyeth Lederlé) has previously shown therapeutic effects for the management of chronic and neuropathic pains. We report here the efficacy of venlafaxine upon acute neurosensory symptoms secondary to oxaliplatin toxicity. A dose of 50 mg of venlafaxine was given orally at the beginning of the oxaliplatin infusion. Patients did not experience any or very low paresthesias, even in the cold. As the results were very dramatic and reproducible, we propose that venlafaxine may be of use in the daily management of oxaliplatin-related neurosensory toxicity.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00001813-200307000-00006DOI Listing

Publication Analysis

Top Keywords

acute neurosensory
8
neurosensory toxicity
8
venlafaxine
5
protection oxaliplatin
4
oxaliplatin acute
4
toxicity venlafaxine
4
venlafaxine venlafaxine
4
venlafaxine effexor
4
effexor wyeth
4
wyeth lederlé
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!